Recent studies have identified the enzyme pyrroline-5-carboxylate reductase 1 (PYCR1) as a potential contributor to cancer progression5,6, but its specific role and underlying mechanisms in lung cancer have not been fully elucidated. Here, PYCR1 is linked to lung cancer.